Vicki Brower. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents, Immunological/adverse effectsAntineoplastic Agents, Immunological/therapeutic useClinical Trials, Phase III as TopicDisease-Free SurvivalHumansMaleProstatic Neoplasms/drug therapyProstatic Neoplasms/mortalityProstatic Neoplasms/pathologyQuinolones/adverse effectsQuinolones/therapeutic useRandomized Controlled Trials as TopicTreatment Outcome
Substances: See more » Antineoplastic Agents, ImmunologicalQuinolonestasquinimod
Year: 2016 PMID: 27345634 DOI: 10.1016/S1470-2045(16)30272-8
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316